학술논문

Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry
Document Type
Article
Source
In: European Journal of Haematology. (European Journal of Haematology, 2024)
Subject
Language
English
ISSN
16000609
09024441